Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/14635
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSawatpanich T.
dc.contributor.authorPetpiboolthai H.
dc.contributor.authorPunyarachun B.
dc.contributor.authorAnupunpisit V.
dc.date.accessioned2021-04-05T03:36:06Z-
dc.date.available2021-04-05T03:36:06Z-
dc.date.issued2010
dc.identifier.issn1252208
dc.identifier.other2-s2.0-79952274286
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/14635-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-79952274286&partnerID=40&md5=677b40e32c1db11536d27f77e4e89b02
dc.description.abstractObjective: To localize and demonstrate the effect of curcumin on vascular endothelial growth factor in diabetic mice kidney induced by streptozotocin Material and Method: Diabetic mice were induced by streptozotocin (60 mg/kg BW). Male mice were divided into three groups, control mice, diabetic mice (DM) and diabetic mice treated with curcumin (DMC) (200 mg/ kg BW). At 4 and 8 weeks, animals were sacrificed and kidneys were processed by immunohistochemistry technique. Results: At the end of 4 and 8 week experiments, glomeruli were slightly enlarged and showed diffuse thickening of the glomerular capillary walls in diabetic mice. Administration with curcumin presented the better improvement and recovery of cells and tissues compared with diabetic mice. Immunohistochemical staining for vascular endothelial growth factor (VEGF) demonstrated that VEGF was mainly detected in the podocytes and renal tubules. There was an increase in VEGF expression in diabetic mice as compared to control. Treatment with curcumin significantly inhibited the expression of VEGF in the kidney tissue of diabetic mice in both 4 and 8 weeks. Comparing the diabetic mice between 4 and 8 week experiments, the expression of VEGF in the podocytes and renal tubules at 8 week were significantly stronger than at 4 week which represented time-dependent change. Nevertheless, the intensity of VEGF was not different in DMC mice when it was compared between 4 and 8 weeks. Conclusion: VEGF immunoreactivity of the podocytes and the renal tubules at 4 and 8 weeks in DM mice showed strong intensity more than in control mice. However, the intensity of VEGF in DMC mice was less when it was compared with DM mice. Moreover, VEGF was a key modulator of angiogenesis and a potent mitogen for endothelial cells. These results demonstrated the potential use of antiangiogenic curcumin as a novel therapeutic agent in diabetic mellitus and maintain normal structure of the kidney.
dc.subjectangiogenesis inhibitor
dc.subjectantineoplastic agent
dc.subjectantineoplastic antibiotic
dc.subjectcurcumin
dc.subjectstreptozocin
dc.subjectvasculotropin
dc.subjectanimal
dc.subjectarticle
dc.subjectchemically induced disorder
dc.subjectexperimental diabetes mellitus
dc.subjectgenetics
dc.subjecthyperglycemia
dc.subjectimmunohistochemistry
dc.subjectkidney
dc.subjectmale
dc.subjectmetabolism
dc.subjectpathology
dc.subjectrat
dc.subjectAngiogenesis Inhibitors
dc.subjectAnimals
dc.subjectAntibiotics, Antineoplastic
dc.subjectAntineoplastic Agents
dc.subjectCurcumin
dc.subjectDiabetes Mellitus, Experimental
dc.subjectHyperglycemia
dc.subjectImmunohistochemistry
dc.subjectKidney
dc.subjectMale
dc.subjectRats
dc.subjectStreptozocin
dc.subjectVascular Endothelial Growth Factors
dc.titleEffect of curcumin on vascular endothelial growth factor expression in diabetic mice kidney induced by streptozotocin
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of the Medical Association of Thailand. Vol 93, No.SUPPL 2 (2010), p.S1-S8
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.